2024-04-032025-04-302025-04-30false15612914TYRONE MEDICAL EQUIPMENT LIMITED2025-12-1847749falseiso4217:GBPxbrli:pure156129142024-04-02156129142025-04-30156129142024-04-032025-04-30156129142024-04-01156129142024-04-02156129142024-04-022024-04-0215612914bus:SmallEntities2024-04-032025-04-3015612914bus:AuditExempt-NoAccountantsReport2024-04-032025-04-3015612914bus:FullAccounts2024-04-032025-04-3015612914bus:PrivateLimitedCompanyLtd2024-04-032025-04-3015612914core:WithinOneYear2025-04-3015612914core:AfterOneYear2025-04-3015612914core:WithinOneYear2024-04-0215612914core:AfterOneYear2024-04-0215612914core:ShareCapital2025-04-3015612914core:SharePremium2025-04-3015612914core:RevaluationReserve2025-04-3015612914core:OtherReservesSubtotal2025-04-3015612914core:RetainedEarningsAccumulatedLosses2025-04-3015612914core:ShareCapital2024-04-0215612914core:SharePremium2024-04-0215612914core:RevaluationReserve2024-04-0215612914core:OtherReservesSubtotal2024-04-0215612914core:RetainedEarningsAccumulatedLosses2024-04-0215612914core:LandBuildings2025-04-3015612914core:PlantMachinery2025-04-3015612914core:Vehicles2025-04-3015612914core:FurnitureFittings2025-04-3015612914core:OfficeEquipment2025-04-3015612914core:NetGoodwill2025-04-3015612914core:IntangibleAssetsOtherThanGoodwill2025-04-3015612914core:ListedExchangeTraded2025-04-3015612914core:UnlistedNon-exchangeTraded2025-04-3015612914core:LandBuildings2024-04-0215612914core:PlantMachinery2024-04-0215612914core:Vehicles2024-04-0215612914core:FurnitureFittings2024-04-0215612914core:OfficeEquipment2024-04-0215612914core:NetGoodwill2024-04-0215612914core:IntangibleAssetsOtherThanGoodwill2024-04-0215612914core:ListedExchangeTraded2024-04-0215612914core:UnlistedNon-exchangeTraded2024-04-0215612914core:LandBuildings2024-04-032025-04-3015612914core:PlantMachinery2024-04-032025-04-3015612914core:Vehicles2024-04-032025-04-3015612914core:FurnitureFittings2024-04-032025-04-3015612914core:OfficeEquipment2024-04-032025-04-3015612914core:NetGoodwill2024-04-032025-04-3015612914core:IntangibleAssetsOtherThanGoodwill2024-04-032025-04-3015612914core:ListedExchangeTraded2024-04-032025-04-3015612914core:UnlistedNon-exchangeTraded2024-04-032025-04-3015612914core:MoreThanFiveYears2024-04-032025-04-3015612914core:Non-currentFinancialInstruments2025-04-3015612914core:Non-currentFinancialInstruments2024-04-0215612914dpl:CostSales2024-04-032025-04-3015612914dpl:DistributionCosts2024-04-032025-04-3015612914core:LandBuildings2024-04-032025-04-3015612914core:PlantMachinery2024-04-032025-04-3015612914core:Vehicles2024-04-032025-04-3015612914core:FurnitureFittings2024-04-032025-04-3015612914core:OfficeEquipment2024-04-032025-04-3015612914dpl:AdministrativeExpenses2024-04-032025-04-3015612914core:NetGoodwill2024-04-032025-04-3015612914core:IntangibleAssetsOtherThanGoodwill2024-04-032025-04-3015612914dpl:GroupUndertakings2024-04-032025-04-3015612914dpl:ParticipatingInterests2024-04-032025-04-3015612914dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-032025-04-3015612914core:ListedExchangeTraded2024-04-032025-04-3015612914dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-032025-04-3015612914core:UnlistedNon-exchangeTraded2024-04-032025-04-3015612914dpl:CostSales2024-04-022024-04-0215612914dpl:DistributionCosts2024-04-022024-04-0215612914core:LandBuildings2024-04-022024-04-0215612914core:PlantMachinery2024-04-022024-04-0215612914core:Vehicles2024-04-022024-04-0215612914core:FurnitureFittings2024-04-022024-04-0215612914core:OfficeEquipment2024-04-022024-04-0215612914dpl:AdministrativeExpenses2024-04-022024-04-0215612914core:NetGoodwill2024-04-022024-04-0215612914core:IntangibleAssetsOtherThanGoodwill2024-04-022024-04-0215612914dpl:GroupUndertakings2024-04-022024-04-0215612914dpl:ParticipatingInterests2024-04-022024-04-0215612914dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-022024-04-0215612914core:ListedExchangeTraded2024-04-022024-04-0215612914dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-022024-04-0215612914core:UnlistedNon-exchangeTraded2024-04-022024-04-0215612914core:NetGoodwill2025-04-3015612914core:IntangibleAssetsOtherThanGoodwill2025-04-3015612914core:LandBuildings2025-04-3015612914core:PlantMachinery2025-04-3015612914core:Vehicles2025-04-3015612914core:FurnitureFittings2025-04-3015612914core:OfficeEquipment2025-04-3015612914core:AfterOneYear2025-04-3015612914core:WithinOneYear2025-04-3015612914core:ListedExchangeTraded2025-04-3015612914core:UnlistedNon-exchangeTraded2025-04-3015612914core:ShareCapital2025-04-3015612914core:SharePremium2025-04-3015612914core:RevaluationReserve2025-04-3015612914core:OtherReservesSubtotal2025-04-3015612914core:RetainedEarningsAccumulatedLosses2025-04-3015612914core:NetGoodwill2024-04-0215612914core:IntangibleAssetsOtherThanGoodwill2024-04-0215612914core:LandBuildings2024-04-0215612914core:PlantMachinery2024-04-0215612914core:Vehicles2024-04-0215612914core:FurnitureFittings2024-04-0215612914core:OfficeEquipment2024-04-0215612914core:AfterOneYear2024-04-0215612914core:WithinOneYear2024-04-0215612914core:ListedExchangeTraded2024-04-0215612914core:UnlistedNon-exchangeTraded2024-04-0215612914core:ShareCapital2024-04-0215612914core:SharePremium2024-04-0215612914core:RevaluationReserve2024-04-0215612914core:OtherReservesSubtotal2024-04-0215612914core:RetainedEarningsAccumulatedLosses2024-04-0215612914core:NetGoodwill2024-04-0115612914core:IntangibleAssetsOtherThanGoodwill2024-04-0115612914core:LandBuildings2024-04-0115612914core:PlantMachinery2024-04-0115612914core:Vehicles2024-04-0115612914core:FurnitureFittings2024-04-0115612914core:OfficeEquipment2024-04-0115612914core:AfterOneYear2024-04-0115612914core:WithinOneYear2024-04-0115612914core:ListedExchangeTraded2024-04-0115612914core:UnlistedNon-exchangeTraded2024-04-0115612914core:ShareCapital2024-04-0115612914core:SharePremium2024-04-0115612914core:RevaluationReserve2024-04-0115612914core:OtherReservesSubtotal2024-04-0115612914core:RetainedEarningsAccumulatedLosses2024-04-0115612914core:AfterOneYear2024-04-032025-04-3015612914core:WithinOneYear2024-04-032025-04-3015612914core:Non-currentFinancialInstrumentscore:CostValuation2024-04-032025-04-3015612914core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-032025-04-3015612914core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-032025-04-3015612914core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-032025-04-3015612914core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-032025-04-3015612914core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-032025-04-3015612914core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-032025-04-3015612914core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-032025-04-3015612914core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-032025-04-3015612914core:Non-currentFinancialInstrumentscore:CostValuation2025-04-3015612914core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-3015612914core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-3015612914core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-3015612914core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-3015612914core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-3015612914core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-3015612914core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-3015612914core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-3015612914core:Non-currentFinancialInstrumentscore:CostValuation2024-04-0215612914core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-0215612914core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-0215612914core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-0215612914core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-0215612914core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-0215612914core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-0215612914core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-0215612914core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-0215612914bus:Director12024-04-032025-04-3015612914bus:Director22024-04-032025-04-30

TYRONE MEDICAL EQUIPMENT LIMITED

Registered Number
15612914
(England and Wales)

Unaudited Financial Statements for the Period ended
30 April 2025

TYRONE MEDICAL EQUIPMENT LIMITED
Company Information
for the period from 3 April 2024 to 30 April 2025

Directors

O’NEILL, Henry Daniel
O’NEILL, Sheena Isabel

Registered Address

C/O Eaccounts Limited Ground Floor, Cardigan House,
Enterprise Park, Castle Court
Swansea
SA7 9LA

Registered Number

15612914 (England and Wales)
TYRONE MEDICAL EQUIPMENT LIMITED
Statement of Financial Position
30 April 2025

Notes

2025

£

£

Fixed assets
Tangible assets31,117
1,117
Current assets
Stocks445,920
Debtors724
Cash at bank and on hand14,504
61,148
Creditors amounts falling due within one year5(52,764)
Net current assets (liabilities)8,384
Total assets less current liabilities9,501
Net assets9,501
Capital and reserves
Called up share capital100
Profit and loss account9,401
Shareholders' funds9,501
The financial statements were approved and authorised for issue by the Board of Directors on 18 December 2025, and are signed on its behalf by:
O’NEILL, Henry Daniel
Director
O’NEILL, Sheena Isabel
Director

Registered Company No. 15612914
TYRONE MEDICAL EQUIPMENT LIMITED
Notes to the Financial Statements
for the period ended 30 April 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Straight line (years)
Office Equipment3
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
2.Average number of employees

2025
Average number of employees during the year1
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
Additions1,7001,700
At 30 April 251,7001,700
Depreciation and impairment
Charge for year583583
At 30 April 25583583
Net book value
At 30 April 251,1171,117
At 02 April 24--
4.Stocks

2025

£
Finished goods45,920
Total45,920
5.Creditors: amounts due within one year

2025

£
Trade creditors / trade payables559
Taxation and social security11,162
Other creditors41,043
Total52,764